DUAL CHECKPOINT ABROGATION IS SYNERGISTIC IN KRAS-MUTANT CANCER

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2015年 / 5卷 / 09期
关键词：
D O I：
10.1158/2159-8290.CD-RW2015-133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：903 / 903
页数：1
相关论文
共 50 条
  • [21] MET inhibition radiosensitizes KRAS-mutant rectal cancer.
    D'Ambrosio, Antonio
    Verginelli, Federica
    Orzan, Francesca
    Albano, Raffaella
    Casanova, Elena
    Luraghi, Paolo
    De Bacco, Francesca
    Bertotti, Andrea
    Trusolino, Livio
    Senetta, Rebecca
    Sapino, Anna
    Del Mastro, Elena
    Gatti, Marco
    Comoglio, Paolo M.
    Boccaccio, Carla
    CANCER RESEARCH, 2021, 81 (13)
  • [22] Dasatinib sensitizes KRAS-mutant colorectal cancer tumors to cetuximab
    Lisa Hutchinson
    Nature Reviews Clinical Oncology, 2011, 8 (4) : 193 - 193
  • [23] A novel combination strategy to treat KRAS-mutant lung cancer
    Peng, R. -W.
    Liang, S. -Q.
    Buhrer, E. D.
    Berezowska, S.
    Marti, T. M.
    Froment, L.
    Yang, H.
    Hall, S. R.
    Vassella, E.
    Yang, Z.
    Kocher, G. J.
    Amrein, M. J.
    Riether, C.
    Ochsenbein, A. F.
    Schmid, R. A.
    BRITISH JOURNAL OF SURGERY, 2019, 106 : 19 - 19
  • [24] Sotorasib effective in KRAS-mutant NSCLC
    Sidaway, Peter
    NATURE REVIEWS CLINICAL ONCOLOGY, 2021, 18 (08) : 470 - 470
  • [25] Immunogenic chemotherapy effectively constrains KRAS-mutant lung cancer
    Wang, D.
    Cong, J.
    Fu, B.
    Zheng, X.
    Sun, R.
    Tian, Z.
    Wei, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1893 - 1893
  • [26] Novel agents for KRAS-mutant NSCLC
    Janne, Pasi A.
    ANNALS OF ONCOLOGY, 2022, 33 : S444 - S444
  • [27] Gene signature of KRAS-mutant cancers
    Kabashima, Kenji
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (10) : 2110 - 2110
  • [28] Cetuximab detrimental in KRAS-mutant mCRC
    Reactions Weekly, 2015, 1562 (1) : 8 - 8
  • [29] Sotorasib effective in KRAS-mutant NSCLC
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2021, 18 : 470 - 470
  • [30] An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo
    Tomoshige, Koichi
    Guo, Minzhe
    Tsuchiya, Tomoshi
    Fukazawa, Takuya
    Fink-Baldauf, Iris M.
    Stuart, William D.
    Naomoto, Yoshio
    Nagayasu, Takeshi
    Maeda, Yutaka
    ONCOGENE, 2018, 37 (28) : 3894 - 3908
12345